Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,94 USD | +6,41% | +37,06% | +75,16% |
Vakgebied
Aantal werknemers: 19
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
73,2
%
| 3 | 18,6 % | 1 | 73,2 % | -58,15% |
License and Other
26,8
%
| 15 | 81,4 % | 1 | 26,8 % | -96,49% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 18 | 100,0 % | 2 | 100,0 % | -89,34% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Garry Neil
CEO | Chief Executive Officer | 70 | 01-02-20 |
Director of Finance/CFO | 40 | 01-01-18 | |
Dino Miano
COO | Chief Operating Officer | - | - |
Lisa Hegg
CTO | Chief Tech/Sci/R&D Officer | - | - |
General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
June Almenoff
BRD | Director/Board Member | 67 | 10-11-21 |
Gilla Kaplan
BRD | Director/Board Member | 76 | 12-10-20 |
Garry Neil
CEO | Chief Executive Officer | 70 | 01-02-20 |
Director/Board Member | 64 | 28-08-12 | |
Mitchell Chan
BRD | Director/Board Member | 43 | 01-12-21 |
Bedrijfsgegevens
Avalo Therapeutics, Inc.
540 Gaither Road Suite 400
20850, Rockville
+410 522 8707
http://www.avalotx.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+75,16% | 16,48 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers AVTX
- Onderneming Avalo Therapeutics, Inc.